Pepcon 2010 - Beijing China

Join us in Spring for the first blossomes in China
and enjoy the clecbration of New Solar Year Nowruz

Theme: After Solution to the Machines of Life
Time: March 21-23, 2010 Venue: Beijing , China

This conference will feature an outstanding experience both scientifically and socially. Also, the oriental culture makes Beijing a fascinating and pleasant place to congregate with old colleagues and new friends to share the most important aspects of many exciting and rapid advances in peptide and protein researches. PepCon-2010 will cover the basic protein science , proteins and diseases enable protein technologies such as human proteome technologies and cancer research, protein kinases as targets of small molecule drug discovery, protein biomarkers, protein analysis and quality control, protein engineering and production, and proteins as drugs-non-Antibody and non-vaccine protein therapeutics.
The conference will take the form of presentations, workshops, round table conferences, exhibitions and posters. It is our hope to provide an alternative exciting event in Asia Pacific Rim that updates the current trend and business model for the peptide and protein professionals. A crucial aspect of our never ending endeavors is to find solutions to difficult scientific problems, and our ultimate goal is to support translation of scientific discovery into application or therapeutics.

Egypt Hepatitis Clinical Trails on way

In collaboraion with AL-Azhar

Girls Collage of Medicine

The project is scheduled to start early 2010 with the Visit of a team of Scientists and Medical professional headed by Prof. Dr. K.S. Abbas Iqbal to Egypt.

2nd International Conference on Drug Dicovery & Therapy - Dubai

Two Abstarcts have been accepted by the review commitee for participation at  ICDDT Confrence in Dubai UAE from 1-4 Feb 2010.

The titiles of the papaers are

1. Molecular Classification of Breast Cancer and Role of Immunohistochemistry for detection of cell types that predicts response to chemotherapy in the clinical Oncology session
2. Cymetiron (Hepron-BM) as Initial Treatment for Chronic Hepatitis C is for infectious diseases session

Better news from Germany

The leading European Institute for Pharmaceutical Biology and Biotechnology Germany, might become the first specialized to conduct in-depth test on two Quantum Bio Energy Medicine molecules QBEM Gene P-53 & Heperon BM

Dr.Debbab Dr.Kamel Prof.Dr.Proksch

Switzerland, Germany, Austria or Netherland - BG Tech Labs

A bit every-where is needed , but most importantly ...integration and supporting industries.
As more new Molecules reach Germany for testing and in-depth analysis they arrive at the end of the Research & Development stages and finally get published and presented to the world
as scientifically patented Molecules.

The paragraph above summarized the work with very sophisticated equipment and materials from more then one scientific Academic and commercial bodies.
Millions of people might imagine or know what a Mercedes Benz from AMG special luxury sport series might cost ..that is roughly the cost of some of the equipment
used in the process ..

Have you any idea what a H-NMR is ?
Do you know for what it's used .

No More Fear - Quantum Bio Energy Medicine %100 Safe - Effective - Economical

08112009041.jpg

P53 & Heperon BM (Cymetron) Tests

The current stage is but a step towards completing the patent requirements new fresh tests are being conducted in various specialized European labs in Germany & Austria.

Physically , Already we have preliminary ( incomplete ) feedback which have led to some changes in the testing methods & techniques as well as the test themselves.

Instead of the HNMR, HPLC the team is considering X-ray refraction or IR Spectroscopy to learn more about the molecules structure and energy.

On the other hand, in the Biological scene samples should arrive to Austria this Monday and immediately Anti-Bio & bio-activity tests will be carried.

Over all we should obtain a very good picture and have the final results & reports well before the beginning of 2010.